Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Ishita Virmani, Alberto Oteo, Michael Dunn, Daniel Vidler, Clair Roper, Jane Officer, Gareth Hardy, Paul I. Dargan, Michael Eddleston, Jamie G. Cooper, Simon L. Hill, Rebecca Macfarlane, Liza Keating, Mark Haden, Simon Hudson & Simon H. L. Thomas. (2023) Accuracy of substance exposure history in patients attending emergency departments after substance misuse; a comparison with biological sample analysis. Clinical Toxicology 61:1, pages 39-46.
Read now
Read now
Benjamin Crulli, Alison M. Dines, Georgina Blanco, Isabelle Giraudon, Florian Eyer, Matthias E. Liechti, Òscar Miró, Knut E. Hovda, Fridtjof Heyerdahl, Christopher Yates, Odd Martin Vallersnes, David M. Wood, Paul I. Dargan, Lukasz Anand, Kurt Anseeuw, Robertas Badaras, Jeffrey Bonnici, Miran Brvar, Blazena Caganova, Feriyde Calýskan, Alessandro Ceschi, Karam Chamoun, Laurence Daveloose, Miguel Galicia, Stefanie Geith, Ketevan Gorozia, Damjan Grenc, Femke Gresnigt, Laura Hondebrink, Gesche Jürgens, Jutta Konstari, Soso Kutubidze, Gabija Laubner, Evangelia Liakoni, Viesturs Liguts, Cathelijne Lyphout, Thomas MacMahon, Bruno Mégarbane, Adrian Moughty, Gabriela Viorela Nitescu, Roberta Noseda, Niall O'Connor, Raido Paasma, Juan Ortega Perez, Marius Perminas, Per Sverre Persett, Kristiina Põld, Jordi Puiguriguer, Julia Radenkova-Saeva, Jan Rulisek, Yasmin Schmid, Irene Scholz, Roberts Stašinskis, Jonas Surkus, Wesley van den Busken, Irma van den Hengel-Koot, Federico Vigorita, Wojciech Waldmanm, William Stephen Waring & Sergej Zacharov. (2022) Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014–2019. Clinical Toxicology 60:12, pages 1318-1327.
Read now
Read now
Mark Haden, Josephine Cashman, Andrew Ketchin, Rebecca Macfarlane, Shabana Issa, Michael Eddleston, Selina Hines, Simon Hudson, Simon L. Hill & Simon H. L. Thomas. (2022) Detection of flubromazolam in patients with suspected non-medical drug use attending emergency departments in the United Kingdom. Clinical Toxicology 60:1, pages 33-37.
Read now
Read now
Georgina Blanco, Dan Vidler, Clair Roper, David M. Wood, Paul I. Dargan, Liza Keating, Rebecca Macfarlane, Stevan Emmett, Graham Johnson, Michael Eddleston, Simon L. Hill & Simon H. L. Thomas. (2021) Acute toxicity from the synthetic cathinone N-ethylpentylone (ephylone) in the United Kingdom. Clinical Toxicology 59:12, pages 1270-1273.
Read now
Read now
Ivo D. Ivanov, Silviya S. Stoykova, Nikola T. Burdzhiev, Ivayla N. Pantcheva & Vasil N. Atanasov. (2021) Synthetic Cannabinoids 5F-QUPIC and MDMB-CHMICA in Plant Material – Identification and Quantification by Gas Chromatography – Mass Spectrometry (GC-MS), Nuclear Magnetic Resonance (NMR), and High-Performance Liquid Chromatography with Diode Array Detection (HPLC-DAD). Analytical Letters 54:16, pages 2600-2610.
Read now
Read now
Valérie Proulx & Benoit Tousignant. (2021) Drugs of abuse and ocular effects. Clinical and Experimental Optometry 104:5, pages 567-578.
Read now
Read now
A. J. Potts, C. Cano, S. H. L. Thomas & S. L. Hill. (2020) Synthetic cannabinoid receptor agonists: classification and nomenclature. Clinical Toxicology 58:2, pages 82-98.
Read now
Read now
Joanna C. White, David M. Wood, Simon L. Hill, Michael Eddleston, Jane Officer, Paul I. Dargan, Michael Dunn & Simon H.L. Thomas. (2019) Acute toxicity following analytically confirmed use of the novel psychoactive substance (NPS) methiopropamine. A report from the Identification of Novel psychoActive substances (IONA) study. Clinical Toxicology 57:7, pages 663-667.
Read now
Read now
Maren Hermanns-Clausen, Dieter Müller, Josephine Kithinji, Verena Angerer, Florian Franz, Florian Eyer, Hartmud Neurath, Gesine Liebetrau & Volker Auwärter. (2018) Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA. Clinical Toxicology 56:6, pages 404-411.
Read now
Read now
Rachelle Abouchedid, Simon Hudson, Natalie Thurtle, Takahiro Yamamoto, James H. Ho, George Bailey, Michelle Wood, Nele Sadones, Christophe P. Stove, Alison Dines, John R. H. Archer, David M. Wood & Paul I. Dargan. (2017) Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015 . Clinical Toxicology 55:5, pages 338-345.
Read now
Read now
Chitra Meyyappan, Loretta Ford & Allister Vale. (2017) Poisoning due to MDMB-CHMICA, a synthetic cannabinoid receptor agonist. Clinical Toxicology 55:2, pages 151-152.
Read now
Read now
Articles from other publishers (35)
Rebekka Syrjanen, Jennifer L. Schumann, Tom Lyons, Ginny McKinnon, Sarah E. Hodgson, Rachelle Abouchedid, Dimitri Gerostamoulos, Zeff Koutsogiannis, John Fitzgerald & Shaun L. Greene. (2023) A risk-based approach to community illicit drug toxicosurveillance: operationalisation of the Emerging Drugs Network of Australia – Victoria (EDNAV) project. International Journal of Drug Policy 122, pages 104251.
Crossref
Crossref
Matteo Scopetti, Donato Morena, Federico Manetti, Alessandro Santurro, Nicola Di Fazio, Stefano D’Errico, Martina Padovano, Paola Frati & Vittorio Fineschi. (2023) Cannabinoids and Brain Damage: A Systematic Review on a Frequently
Overlooked Issue. Current Pharmaceutical Biotechnology 24:6, pages 741-757.
Crossref
Crossref
Xinze Liu, Wei Liu, Ping Xiang, Taijun Hang, Yan Shi, Linna Yue & Hui Yan. (2022) Metabolism of ADB-4en-PINACA in Zebrafish and Rat Liver Microsomes Determined by Liquid Chromatography–High Resolution Mass Spectrometry. Journal of Analytical Chemistry 77:8, pages 1036-1046.
Crossref
Crossref
Liesl K Janssens, Dimitri Boeckaerts, Simon Hudson, Daria Morozova, Annelies Cannaert, David M Wood, Caitlin Wolfe, Bernard De Baets, Michiel Stock, Paul I Dargan & Christophe P Stove. (2022) Machine Learning to Assist in Large-Scale, Activity-Based Synthetic Cannabinoid Receptor Agonist Screening of Serum Samples. Clinical Chemistry 68:7, pages 906-916.
Crossref
Crossref
Sam Craft, Michael Dunn, Dan Vidler, Jane Officer, Ian S. Blagbrough, Christopher R. Pudney, Graeme Henderson, Ahmed Abouzeid, Paul I. Dargan, Michael Eddleston, Jamie Cooper, Simon L. Hill, Clair Roper, Tom P. Freeman & Simon H. L. Thomas. (2022) Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act. Addiction.
Crossref
Crossref
Franziska Gaunitz & Hilke Andresen-Streichert. (2021) Analytical findings in a non-fatal intoxication with the synthetic cannabinoid 5F-ADB (5F-MDMB-PINACA): a case report. International Journal of Legal Medicine 136:2, pages 577-589.
Crossref
Crossref
John R.H. Archer. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
131
156
.
Martin F. Casey & Alex F. Manini. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
415
446
.
Emma Partridge, Sam Alfred, Andrew Camilleri, Hannah Green, Daniel Haustead, Chris Kostakis, Jake Mallon, Kerryn Mason, April Rivers‐Kennedy & Peter Stockham. (2021) Establishing the protocols for the South Australian Emergency Department Admission Blood Psychoactive Testing (EDABPT) programme for drug surveillance. Emergency Medicine Australasia 33:5, pages 883-887.
Crossref
Crossref
Katharina Elisabeth Grafinger, Annelies Cannaert, Adam Ametovski, Eric Sparkes, Elizabeth Cairns, Samuel D. Banister, Volker Auwärter & Christophe P. Stove. (2021)
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB
1
receptor activation assays—Part II: Structure activity relationship assessment via a β‐arrestin recruitment assay
. Drug Testing and Analysis 13:7, pages 1402-1411.
Crossref
Crossref
Michal Ordak, Aleksandra Zmysłowska, Miłosz Bielski, Daniel Rybak, Maja Tomaszewska, Katarzyna Wyszomierska, Aleksandra Kmiec, Natalia Garlicka, Maria Zalewska, Michal Zalewski, Tadeusz Nasierowski, Elzbieta Muszynska & Magdalena Bujalska-Zadrozny. (2021) Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports. Frontiers in Psychiatry 12.
Crossref
Crossref
Chris Bladen, Somayeh Mirlohi, Marina Santiago, Mitchell Longworth, Michael Kassiou, Sam Banister & Mark Connor. (2021) Modulation of human T-type calcium channels by synthetic cannabinoid receptor agonists in vitro. Neuropharmacology 187, pages 108478.
Crossref
Crossref
Wing-sum Chan, George Fai Wong, Chi-wai Hung, Yau-nga Wong, Kit-mai Fung, Wai-kit Lee, Kwok-Leung Dao, Chung-wing Leung, Kam-moon Lo, Wing-man Lee & Bobbie Kwok-keung Cheung. (2020) Interpol review of toxicology 2016–2019. Forensic Science International: Synergy 2, pages 563-607.
Crossref
Crossref
Islam Amine Larabi, Mohammed Riffi, Nicolas Fabresse, Isabelle Etting & Jean-Claude Alvarez. (2019) Validation of an UPLC-MS/MS method for the determination of sixteen synthetic cannabinoids in human hair. Application to document chronic use of JWH-122 following a non-fatal overdose. Toxicologie Analytique et Clinique 31:4, pages 283-292.
Crossref
Crossref
Elise Wouters, Lukas Mogler, Annelies Cannaert, Volker Auwärter & Christophe Stove. (2019)
Functional evaluation of carboxy metabolites of synthetic cannabinoid receptor agonists featuring scaffolds based on L‐valine or L‐
tert
‐leucine
. Drug Testing and Analysis 11:8, pages 1183-1191.
Crossref
Crossref
Caitlin E. Wolfe, David M. Wood, Alison Dines, Benjamin P. Whatley, Christopher Yates, Fridtjof Heyerdahl, Knut Erik Hovda, Isabelle Giraudon, Paul I. Dargan, Kurt Anseeuw, Robertas Badaras, Jeffrey Bonnici, Miran Brvar, Blazena Caganova, Alessandro Ceschi, Florian Eyer, Miguel Galicia, Stefanie Geith, Johan Gillebeert, Damjan Grenc, Ketevan Gorozia, Karim Jaffal, Gesche Jürgens, Piotr Maciej Kabata, Iarlaith Kennedy, Jutta Konstari, Soso Kutubidze, Gabija Laubner, Evangelia Liakoni, Matthias E. Liechti, Cathelijne Lyphout, Bruno Mégarbane, Òscar Miró, Adrian Moughty, Laura Müller, Niall O'Connor, Raido Paasma, Juan Ortega Perez, Marius Perminas, Per Sverre Persett, Kristiina Põld, Jordi Puiguriguer, Julia Radenkova-Saeva, Jan Rulisek, Yasmin Schmid, Irene Scholz, Radhika Sopirala, Jonas Surkus, Ibolya Toth, Odd Martin Vallersnes, Federico Vigorita, Wojciech Waldman, W. Stephen Waring & Sergej Zacharov. (2019) Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set. NeuroToxicology 73, pages 183-187.
Crossref
Crossref
Katharina Elisabeth Grafinger, Harpreet Kaur Mandhair, Alain Broillet, Jürg Gertsch & Wolfgang Weinmann. (2019) Cytotoxicity of the synthetic cannabinoids 5C-AKB48, 5F-MDMB-PINACA, ADB-CHMINACA, MDMB-CHMICA and NM-2201 in A549 and TR146 cell lines. Forensic Toxicology 37:2, pages 398-411.
Crossref
Crossref
David McCutcheon, Mohan Raghavan, Jessamine Soderstrom, Francois Oosthuizen, Bianca Douglas, Ellen MacDonald & Daniel Fatovich. (2018) An early warning system for emerging drugs of concern in the emergency department: Protocol for the Western Australian Illicit Substance Evaluation (WISE) study. Emergency Medicine Australasia 31:3, pages 411-416.
Crossref
Crossref
Federica Foti, Matteo Marti, Andrea Ossato, Sabrine Bilel, Eugenio Sangiorgi, Francesco Botrè, Bruna Cerbelli, Alfonso Baldi & Fabio De-Giorgio. (2018) Phenotypic effects of chronic and acute use of methiopropamine in a mouse model. International Journal of Legal Medicine 133:3, pages 811-820.
Crossref
Crossref
Ivo D. Ivanov, Silviya Stoykova, Elka Ivanova, Aleksandrina Vlahova, Nikola Burdzhiev, Ivayla Pantcheva & Vasil N. Atanasov. (2019) A case of 5F-ADB / FUB-AMB abuse: Drug-induced or drug-related death?. Forensic Science International 297, pages 372-377.
Crossref
Crossref
Michael B. Gatch & Michael J. Forster. (2019) Cannabinoid-like effects of five novel carboxamide synthetic cannabinoids. NeuroToxicology 70, pages 72-79.
Crossref
Crossref
Franziska Gaunitz, Sabrina Lehmann, Andreas Thomas, Mario Thevis, Markus A. Rothschild & Katja Mercer-Chalmers-Bender. (2018) Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication. International Journal of Legal Medicine 132:6, pages 1645-1657.
Crossref
Crossref
Lukas Mogler, Florian Franz, Maurice Wilde, Laura M. Huppertz, Sebastian Halter, Verena Angerer, Bjoern Moosmann & Volker Auwärter. (2018) Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples. Drug Testing and Analysis 10:9, pages 1417-1429.
Crossref
Crossref
Hideyuki Maeda, Erika Nagashima, Yukiko K. Hayashi, Ruri Kikura-Hanajiri & Ken-ichi Yoshida. (2018) MDMB-CHMICA induces thrashing behavior, bradycardia, and slow pressor response in a CB1- and CB2-receptor-dependent manner in conscious rats. Forensic Toxicology 36:2, pages 313-319.
Crossref
Crossref
Pal Pacher, Sabine Steffens, György Haskó, Thomas H. Schindler & George Kunos. (2017) Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Nature Reviews Cardiology 15:3, pages 151-166.
Crossref
Crossref
Simon L Hill, Michael Dunn, Céline Cano, Suzannah J Harnor, Ian R Hardcastle, Johann Grundlingh, Paul I Dargan, David M Wood, Simon Tucker, Thomas Bartram & Simon H L Thomas. (2018) Human Toxicity Caused by Indole and Indazole Carboxylate Synthetic Cannabinoid Receptor Agonists: From Horizon Scanning to Notification. Clinical Chemistry 64:2, pages 346-354.
Crossref
Crossref
Vera Coopman & Jan Cordonnier. (2018) ‘Spice-like’ herbal incense laced with the synthetic opioid U-47700. Toxicologie Analytique et Clinique 30:1, pages 75-79.
Crossref
Crossref
Michael Evans-Brown & Roumen Sedefov. 2018. New Psychoactive Substances. New Psychoactive Substances
3
49
.
Simon L. Hill & Paul I. Dargan. 2018. New Psychoactive Substances. New Psychoactive Substances
475
494
.
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
Florian Franz, Verena Angerer, Bjoern Moosmann & Volker Auwärter. (2017) Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples. Drug Testing and Analysis 9:5, pages 744-753.
Crossref
Crossref
Martijn D.P. Risseeuw, Peter Blanckaert, Vera Coopman, Stijn Van Quekelberghe, Serge Van Calenbergh & Jan Cordonnier. (2017) Identification of a new tert -leucinate class synthetic cannabinoid in powder and “spice-like” herbal incenses: Methyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (5F-MDMB-PICA). Forensic Science International 273, pages 45-52.
Crossref
Crossref
Matilda Bäckberg, Luiza Tworek, Olof Beck & Anders Helander. (2016) Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project. Journal of Medical Toxicology 13:1, pages 52-60.
Crossref
Crossref
Colin Davidson, Jolanta Opacka-Juffry, Angel Arevalo-Martin, Daniel Garcia-Ovejero, Eduardo Molina-Holgado & Francisco Molina-Holgado. 2017. Cannabinoid Pharmacology. Cannabinoid Pharmacology
135
168
.
. (2016) Methadone. Reactions Weekly 1619:1, pages 122-122.
Crossref
Crossref